A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

Atazanavir Twice Daily

NCT00357721 ·Status: COMPLETED ·Phase: PHASE1

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

NCT00357188 ·Status: COMPLETED ·Phase: PHASE1

A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy

NCT00067782 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment

NCT00004581 ·Status: COMPLETED ·Phase: PHASE3

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens

NCT00940771 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression

NCT01511809 ·Status: COMPLETED ·Phase: PHASE3

Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment

NCT00006591 ·Status: UNKNOWN ·Phase: NA

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

NCT00035932 ·Status: COMPLETED ·Phase: PHASE3

A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

NCT00002364 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients

NCT02473328 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

NCT00122577 ·Status: TERMINATED ·Phase: PHASE2

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

NCT00814879 ·Status: COMPLETED ·Phase: NA

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)

NCT00122603 ·Status: COMPLETED ·Phase: PHASE2

A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen

NCT00135447 ·Status: COMPLETED

A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors

NCT00004580 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

NCT00326716 ·Status: COMPLETED ·Phase: PHASE1

Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study

NCT02034838 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

NCT01803074 ·Status: COMPLETED ·Phase: PHASE2

Phase IIB Pilot of Atazanavir + Raltegravir

NCT00768989 ·Status: TERMINATED ·Phase: PHASE2

Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC

NCT01620944 ·Status: TERMINATED ·Phase: PHASE3

A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia

NCT02542852 ·Status: COMPLETED ·Phase: PHASE2

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

NCT00552240 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment

NCT01448707 ·Status: COMPLETED ·Phase: PHASE3

ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past

NCT00004582 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen

NCT00135343 ·Status: COMPLETED ·Phase: PHASE3